Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India · Delayed Price · Currency is INR 19.36
+1.67 (9.44%)
At close: Jul 9, 2026
BOM:531015 Market Cap
BOM:531015 has a market cap or net worth of 223.78 million as of July 10, 2026. Its market cap has increased by 60.52% in one year.
Market Cap
223.78M
Enterprise Value
214.86M
Revenue
80.25M
Ranking
n/a
PE Ratio
92.00
Stock Price
19.36
Market Cap Chart
Since April 15, 2008, BOM:531015's market cap has increased from 32.40M to 223.78M, an increase of 590.71%. That is a compound annual growth rate of 11.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 223.78M | 71.20% |
| Dec 31, 2025 | 130.71M | 38.30% |
| Dec 31, 2024 | 94.51M | 357.87% |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kimia Biosciences | 1.47B |
| Smruthi Organics | 1.40B |
| Tyche Industries | 1.25B |
| Krebs Biochemicals & Industries | 1.18B |
| Vasundhara Rasayans | 555.87M |
| Bacil Pharma | 550.87M |
| Crestchem | 393.45M |
| Alfavision Overseas (India) | 309.90M |